{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T11:44:38Z","timestamp":1785843878325,"version":"3.56.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T00:00:00Z","timestamp":1667952000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T00:00:00Z","timestamp":1667952000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81874181"],"award-info":[{"award-number":["81874181"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31701108"],"award-info":[{"award-number":["31701108"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81701749"],"award-info":[{"award-number":["81701749"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-022-01874-x","type":"journal-article","created":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T21:20:20Z","timestamp":1668028820000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Fibrinogen promotes gallbladder cancer cell metastasis and extravasation by inducing ICAM1 expression"],"prefix":"10.1007","volume":"40","author":[{"given":"Chengkai","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongsheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liguo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu-an","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenguang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runfa","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maolan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajun","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijun","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3765-1080","authenticated-orcid":false,"given":"Yingbin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,9]]},"reference":[{"issue":"3","key":"1874_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"1874_CR2","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1136\/gutjnl-2018-316039","volume":"68","author":"M Li","year":"2019","unstructured":"Li M, et al. Genomic ERBB2\/ERBB3 mutations promote PD-L1-mediated immune escape in gallbladder cancer: a whole-exome sequencing analysis. Gut. 2019;68(6):1024\u201333.","journal-title":"Gut"},{"issue":"11","key":"1874_CR3","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1080\/0284186X.2018.1478124","volume":"57","author":"P Lindner","year":"2018","unstructured":"Lindner P, Holmberg E, Hafstrom L. Gallbladder cancer: no improvement in survival over time in a Swedish population. Acta Oncol. 2018;57(11):1482\u20139.","journal-title":"Acta Oncol"},{"issue":"9","key":"1874_CR4","first-page":"697","volume":"58","author":"T Ren","year":"2020","unstructured":"Ren T, et al. Analysis of treatment modalities and prognosis of patients with gallbladder cancer in China from 2010 to 2017. Zhonghua Wai Ke Za Zhi. 2020;58(9):697\u2013706.","journal-title":"Zhonghua Wai Ke Za Zhi"},{"issue":"2","key":"1874_CR5","doi-asserted-by":"publisher","first-page":"176","DOI":"10.4240\/wjgs.v13.i2.176","volume":"13","author":"T Ren","year":"2021","unstructured":"Ren T, et al. Prognostic significance of regional lymphadenectomy in T1b gallbladder cancer: results from 24 hospitals in China. World J Gastrointest Surg. 2021;13(2):176\u201386.","journal-title":"World J Gastrointest Surg"},{"key":"1874_CR6","doi-asserted-by":"publisher","DOI":"10.1097\/cm9.0000000000002067","author":"X Wu","year":"2022","unstructured":"Wu X, et al. Hepatopancreatoduodenectomy for advanced biliary malignancies. Chin Med J. 2022. https:\/\/doi.org\/10.1097\/cm9.0000000000002067.","journal-title":"Chin Med J"},{"issue":"12","key":"1874_CR7","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1001\/jama.2018.11815","volume":"320","author":"I Baiu","year":"2018","unstructured":"Baiu I, Visser B. Gallbladder cancer. JAMA. 2018;320(12):1294.","journal-title":"JAMA"},{"issue":"1","key":"1874_CR8","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/s41392-020-00324-2","volume":"5","author":"X Song","year":"2020","unstructured":"Song X, et al. Overview of current targeted therapy in gallbladder cancer. Signal Transduct Target Ther. 2020;5(1):230.","journal-title":"Signal Transduct Target Ther"},{"issue":"4","key":"1874_CR9","doi-asserted-by":"publisher","first-page":"498","DOI":"10.21037\/hbsn-20-846","volume":"10","author":"XY Cui","year":"2021","unstructured":"Cui XY, et al. Modified FOLFIRINOX for unresectable locally advanced or metastatic gallbladder cancer, a comparison with GEMOX regimen. Hepatobiliary Surg Nutr. 2021;10(4):498\u2013506.","journal-title":"Hepatobiliary Surg Nutr"},{"issue":"10","key":"1874_CR10","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.15252\/embr.201744147","volume":"18","author":"XS Wu","year":"2017","unstructured":"Wu XS, et al. LncRNA-PAGBC acts as a microRNA sponge and promotes gallbladder tumorigenesis. EMBO Rep. 2017;18(10):1837\u201353.","journal-title":"EMBO Rep"},{"issue":"1","key":"1874_CR11","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12943-014-0276-y","volume":"14","author":"YJ Shu","year":"2015","unstructured":"Shu YJ, et al. SPOCK1 as a potential cancer prognostic marker promotes the proliferation and metastasis of gallbladder cancer cells by activating the PI3K\/AKT pathway. Mol Cancer. 2015;14(1):12.","journal-title":"Mol Cancer"},{"issue":"8","key":"1874_CR12","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1038\/ng.3030","volume":"46","author":"M Li","year":"2014","unstructured":"Li M, et al. Whole-exome and targeted gene sequencing of gallbladder carcinoma identifies recurrent mutations in the ErbB pathway. Nat Genet. 2014;46(8):872\u20136.","journal-title":"Nat Genet"},{"key":"1874_CR13","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1111\/j.1749-6632.2001.tb03535.x","volume":"936","author":"CM Redman","year":"2001","unstructured":"Redman CM, Xia H. Fibrinogen biosynthesis. Assembly, intracellular degradation, and association with lipid synthesis and secretion. Ann N Y Acad Sci. 2001;936:480\u201395.","journal-title":"Ann N Y Acad Sci"},{"issue":"6","key":"1874_CR14","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1182\/blood-2018-07-818211","volume":"133","author":"JP Luyendyk","year":"2019","unstructured":"Luyendyk JP, Schoenecker JG, Flick MJ. The multifaceted role of fibrinogen in tissue injury and inflammation. Blood. 2019;133(6):511\u201320.","journal-title":"Blood"},{"issue":"3","key":"1874_CR15","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.1161\/ATVBAHA.117.308564","volume":"37","author":"S Kattula","year":"2017","unstructured":"Kattula S, Byrnes JR, Wolberg AS. Fibrinogen and fibrin in hemostasis and thrombosis. Arterioscler Thromb Vasc Biol. 2017;37(3):e13-21.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"1874_CR16","doi-asserted-by":"publisher","first-page":"284","DOI":"10.3324\/haematol.2019.236901","volume":"105","author":"R Vilar","year":"2020","unstructured":"Vilar R, et al. Fibrin(ogen) in human disease: both friend and foe. Haematologica. 2020;105(2):284\u201396.","journal-title":"Haematologica"},{"issue":"10","key":"1874_CR17","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.ctrv.2015.10.002","volume":"41","author":"C Perisanidis","year":"2015","unstructured":"Perisanidis C, et al. Prognostic role of pretreatment plasma fibrinogen in patients with solid tumors: a systematic review and meta-analysis. Cancer Treat Rev. 2015;41(10):960\u201370.","journal-title":"Cancer Treat Rev"},{"key":"1874_CR18","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1186\/1471-2407-14-566","volume":"14","author":"YJ Shu","year":"2014","unstructured":"Shu YJ, et al. Clinical and prognostic significance of preoperative plasma hyperfibrinogenemia in gallbladder cancer patients following surgical resection: a retrospective and in vitro study. BMC Cancer. 2014;14:566.","journal-title":"BMC Cancer"},{"issue":"10","key":"1874_CR19","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1016\/j.ejso.2018.07.052","volume":"44","author":"Y Lin","year":"2018","unstructured":"Lin Y, et al. Clinical significance of plasma D-dimer and fibrinogen in digestive cancer: a systematic review and meta-analysis. Eur J Surg Oncol. 2018;44(10):1494\u2013503.","journal-title":"Eur J Surg Oncol"},{"key":"1874_CR20","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1111\/j.1749-6632.2001.tb03525.x","volume":"936","author":"PJ Simpson-Haidaris","year":"2001","unstructured":"Simpson-Haidaris PJ, Rybarczyk B. Tumors and fibrinogen. The role of fibrinogen as an extracellular matrix protein. Ann N Y Acad Sci. 2001;936:406\u201325.","journal-title":"Ann N Y Acad Sci"},{"issue":"12","key":"1874_CR21","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1007\/s00432-017-2493-4","volume":"143","author":"F Zhang","year":"2017","unstructured":"Zhang F, et al. Fibrinogen promotes malignant biological tumor behavior involving epithelial-mesenchymal transition via the p-AKT\/p-mTOR pathway in esophageal squamous cell carcinoma. J Cancer Res Clin Oncol. 2017;143(12):2413\u201324.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"5","key":"1874_CR22","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.12947","volume":"31","author":"L Dzikowski","year":"2021","unstructured":"Dzikowski L, et al. Fibrinogen in the glioblastoma microenvironment contributes to the invasiveness of brain tumor-initiating cells. Brain Pathol. 2021;31(5): e12947.","journal-title":"Brain Pathol"},{"issue":"23","key":"1874_CR23","first-page":"6966","volume":"62","author":"JS Palumbo","year":"2002","unstructured":"Palumbo JS, et al. Spontaneous hematogenous and lymphatic metastasis, but not primary tumor growth or angiogenesis, is diminished in fibrinogen-deficient mice. Cancer Res. 2002;62(23):6966\u201372.","journal-title":"Cancer Res"},{"issue":"5","key":"1874_CR24","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1111\/j.1349-7006.2009.01115.x","volume":"100","author":"S Zheng","year":"2009","unstructured":"Zheng S, et al. Platelets and fibrinogen facilitate each other in protecting tumor cells from natural killer cytotoxicity. Cancer Sci. 2009;100(5):859\u201365.","journal-title":"Cancer Sci"},{"issue":"19","key":"1874_CR25","doi-asserted-by":"publisher","first-page":"4235","DOI":"10.1158\/0008-5472.CAN-15-0964","volume":"75","author":"GN Adams","year":"2015","unstructured":"Adams GN, et al. Colon cancer growth and dissemination relies upon thrombin, stromal PAR-1, and fibrinogen. Cancer Res. 2015;75(19):4235\u201343.","journal-title":"Cancer Res"},{"issue":"7","key":"1874_CR26","doi-asserted-by":"publisher","first-page":"2634","DOI":"10.1158\/0008-5472.CAN-09-3465","volume":"70","author":"KA Steinbrecher","year":"2010","unstructured":"Steinbrecher KA, et al. Colitis-associated cancer is dependent on the interplay between the hemostatic and inflammatory systems and supported by integrin \u03b1(M)\u03b2(2) engagement of fibrinogen. Cancer Res. 2010;70(7):2634\u201343.","journal-title":"Cancer Res"},{"issue":"10","key":"1874_CR27","doi-asserted-by":"publisher","first-page":"2480","DOI":"10.1111\/jth.15440","volume":"19","author":"BK Sharma","year":"2021","unstructured":"Sharma BK, et al. Fibrinogen activates focal adhesion kinase (FAK) promoting colorectal adenocarcinoma growth. J Thromb Haemost. 2021;19(10):2480\u201394.","journal-title":"J Thromb Haemost"},{"issue":"5","key":"1874_CR28","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1016\/j.jhep.2021.06.023","volume":"75","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, et al. Single-cell RNA-sequencing atlas reveals an MDK-dependent immunosuppressive environment in ErbB pathway-mutated gallbladder cancer. J Hepatol. 2021;75(5):1128\u201341.","journal-title":"J Hepatol"},{"issue":"8","key":"1874_CR29","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1111\/j.1538-7836.2005.01365.x","volume":"3","author":"MW Mosesson","year":"2005","unstructured":"Mosesson MW. Fibrinogen and fibrin structure and functions. J Thromb Haemost. 2005;3(8):1894\u2013904.","journal-title":"J Thromb Haemost"},{"issue":"3","key":"1874_CR30","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1002\/JLB.2MR0220-549R","volume":"108","author":"TM Bui","year":"2020","unstructured":"Bui TM, Wiesolek HL, Sumagin R. ICAM-1: a master regulator of cellular responses in inflammation, injury resolution, and tumorigenesis. J Leukoc Biol. 2020;108(3):787\u201399.","journal-title":"J Leukoc Biol"},{"key":"1874_CR31","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.2147\/CMAR.S157092","volume":"11","author":"NU Tariq","year":"2019","unstructured":"Tariq NU, McNamara MG, Valle JW. Biliary tract cancers: current knowledge, clinical candidates and future challenges. Cancer Manag Res. 2019;11:2623\u201342.","journal-title":"Cancer Manag Res"},{"issue":"3","key":"1874_CR32","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/s41419-018-0444-x","volume":"9","author":"YY Ye","year":"2018","unstructured":"Ye YY, et al. MicroRNA-30a-5p inhibits gallbladder cancer cell proliferation, migration and metastasis by targeting E2F7. Cell Death Dis. 2018;9(3):410.","journal-title":"Cell Death Dis"},{"issue":"3","key":"1874_CR33","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/cdd.2016.146","volume":"24","author":"YJ Shu","year":"2017","unstructured":"Shu YJ, et al. MicroRNA-29c-5p suppresses gallbladder carcinoma progression by directly targeting CPEB4 and inhibiting the MAPK pathway. Cell Death Differ. 2017;24(3):445\u201357.","journal-title":"Cell Death Differ"},{"issue":"1","key":"1874_CR34","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.canlet.2009.02.020","volume":"281","author":"JW Wang","year":"2009","unstructured":"Wang JW, et al. Identification of metastasis-associated proteins involved in gallbladder carcinoma metastasis by proteomic analysis and functional exploration of chloride intracellular channel 1. Cancer Lett. 2009;281(1):71\u201381.","journal-title":"Cancer Lett"},{"key":"1874_CR35","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.biomaterials.2018.01.053","volume":"161","author":"X Cui","year":"2018","unstructured":"Cui X, et al. Hacking macrophage-associated immunosuppression for regulating glioblastoma angiogenesis. Biomaterials. 2018;161:164\u201378.","journal-title":"Biomaterials"},{"issue":"1","key":"1874_CR36","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.cell.2010.03.014","volume":"141","author":"BZ Qian","year":"2010","unstructured":"Qian BZ, Pollard JW. Macrophage diversity enhances tumor progression and metastasis. Cell. 2010;141(1):39\u201351.","journal-title":"Cell"},{"issue":"1\u20132","key":"1874_CR37","first-page":"13","volume":"307","author":"N Tyagi","year":"2008","unstructured":"Tyagi N, et al. Fibrinogen induces endothelial cell permeability. Mol Cell Biochem. 2008;307(1\u20132):13\u201322.","journal-title":"Mol Cell Biochem"},{"issue":"1","key":"1874_CR38","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/jcbfm.2011.144","volume":"32","author":"N Muradashvili","year":"2012","unstructured":"Muradashvili N, et al. Fibrinogen-induced increased pial venular permeability in mice. J Cereb Blood Flow Metab. 2012;32(1):150\u201363.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"8","key":"1874_CR39","doi-asserted-by":"publisher","first-page":"2966","DOI":"10.1111\/cas.14942","volume":"112","author":"T Tomita","year":"2021","unstructured":"Tomita T, Kato M, Hiratsuka S. Regulation of vascular permeability in cancer metastasis. Cancer Sci. 2021;112(8):2966\u201374.","journal-title":"Cancer Sci"},{"issue":"10","key":"1874_CR40","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1158\/2326-6066.CIR-21-0062","volume":"9","author":"Y Yang","year":"2021","unstructured":"Yang Y, et al. Bispecific CAR T Cells against EpCAM and Inducible ICAM-1 overcome antigen heterogeneity and generate superior antitumor responses. Cancer Immunol Res. 2021;9(10):1158\u201374.","journal-title":"Cancer Immunol Res"},{"issue":"9","key":"1874_CR41","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.2174\/138920111798281144","volume":"12","author":"H Raghu","year":"2011","unstructured":"Raghu H, Flick MJ. Targeting the coagulation factor fibrinogen for arthritis therapy. Curr Pharm Biotechnol. 2011;12(9):1497\u2013506.","journal-title":"Curr Pharm Biotechnol"},{"issue":"1","key":"1874_CR42","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1111\/j.1538-7836.2007.02808.x","volume":"6","author":"A Sahni","year":"2008","unstructured":"Sahni A, et al. Fibrinogen synthesized by cancer cells augments the proliferative effect of fibroblast growth factor-2 (FGF-2). J Thromb Haemost. 2008;6(1):176\u201383.","journal-title":"J Thromb Haemost"},{"issue":"6","key":"1874_CR43","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1055\/s-0037-1613412","volume":"89","author":"Y Roche","year":"2003","unstructured":"Roche Y, et al. Fibrinogen mediates bladder cancer cell migration in an ICAM-1-dependent pathway. Thromb Haemost. 2003;89(6):1089\u201397.","journal-title":"Thromb Haemost"},{"key":"1874_CR44","doi-asserted-by":"publisher","first-page":"14035","DOI":"10.1038\/ncomms14035","volume":"8","author":"C Huang","year":"2017","unstructured":"Huang C, et al. Tumour-derived Interleukin 35 promotes pancreatic ductal adenocarcinoma cell extravasation and metastasis by inducing ICAM1 expression. Nat Commun. 2017;8:14035.","journal-title":"Nat Commun"},{"issue":"1","key":"1874_CR45","doi-asserted-by":"publisher","first-page":"4867","DOI":"10.1038\/s41467-021-25189-z","volume":"12","author":"R Taftaf","year":"2021","unstructured":"Taftaf R, et al. ICAM1 initiates CTC cluster formation and trans-endothelial migration in lung metastasis of breast cancer. Nat Commun. 2021;12(1):4867.","journal-title":"Nat Commun"},{"issue":"7","key":"1874_CR46","first-page":"2033","volume":"60","author":"BJ Rybarczyk","year":"2000","unstructured":"Rybarczyk BJ, Simpson-Haidaris PJ. Fibrinogen assembly, secretion, and deposition into extracellular matrix by MCF-7 human breast carcinoma cells. Cancer Res. 2000;60(7):2033\u20139.","journal-title":"Cancer Res"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-022-01874-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-022-01874-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-022-01874-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T03:31:23Z","timestamp":1673839883000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-022-01874-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,9]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1]]}},"alternative-id":["1874"],"URL":"https:\/\/doi.org\/10.1007\/s12032-022-01874-x","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,9]]},"assertion":[{"value":"3 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The human study was approved by the Institutional Ethical Board of Xinhua Hospital and informed consent was obtained from all patients with GBC prior to enrollment of the study. All of the animal studies were approved by the Institutional Animal Care and Use Committee of Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. All the animal experiments were performed according to our institution's guidelines for the use of laboratory animals.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"10"}}